Links Medical launches diabetes meters for pets
IRVINE, Calif. – Links Medical Products Animal Health Group on Thursday announced the introduction of their new Pet Gluco blood-glucose monitoring system for dogs and cats.
"With diabetes in dogs and cats on the rise, we believe our new, easy to use Pet Gluco system is the cost-effective device veterinarians and those doing glucose monitoring of their pets at home will want to use," stated Patrick Buckley, president Links Medical Products. "Caring for pets with diabetes can become costly. Our new diabetic pet monitoring system will help alleviate some of that cost and provide the fast, sure results needed to effectively render care."
The Pet Gluco system offers veterinarians — plus those with diabetic dogs and cats at home — a fast, easy-to-use, affordable way to monitor their pets.
Pet Gluco is calibrated specifically for dogs and for cats. Other features include a large display where test results are visible within five seconds after insertion of the test strip, and a quick-eject button for easy disposal of strips.
No comments found
Valeant Consumer Products: Ocean Saline Nasal Sprays most recommended by pharmacists for 15 years
BRIDGEWATER, N.J. — Valeant Consumer Products recently announced that its line of Ocean Saline Nasal Sprays has been the most recommended by pharmacists for 15 years running.
Ocean offers nonmedicated relief from dry and irritated nasal passages due to allergies, colds, flu, sinusitis and rhinitis. The nasal spray is gentle enough for infants and has three delivery options — standing the bottle upright delivers a spray; horizontally, a stream; and upside-down, a drop.
The company’s Ocean Complete Sinus Rinse provides pre-mixed, easy-to-use two-in-one nasal saline therapy: a special nozzle for nasal sinus irrigation and a saline mist applicator for nasal moisturizing. It is also sterile and preservative-free.
No comments found
Study: Aspirin effective in preventing clots following joint replacement surgery
PHILADELPHIA – Recent research from the Rothman Institute at Jefferson has shown aspirin to be just as effective in preventing clots — specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the lungs following joint replacement surgery — Thomas Jefferson University announced Wednesday.
“While warfarin is successful in the prophylactic prevention of clots it can also lead to increased bleeding, infections and hospital readmissions,” stated Javad Parvizi, director of Research at the Rothman Institute and lead author on the study.
The study compared the outcomes of 26,415 patients who underwent joint replacement surgery at the Rothman Institute between 2000 and 2011; 1,824 of whom received aspirin and 24,567 of whom received warfarin prophylactically prior to surgery. Both groups were monitored for up to 90 days postoperatively.
Their results showed the overall rate of pulmonary embolism to be significantly lower in the patients who received aspirin (0.2% or four in 1,824) versus those who received warfarin (1% or 92 in 9028). In addition, hematoma, a leakage of blood external to the blood vessel or a leakage of fluid known as a seroma, wound problems, acute infection and 90-day mortality rates were also lower in the aspirin group.
“Our study shows that aspirin is a viable alternative to warfarin in healthy patients, with better results in preventing clots, and a lower rate of bleeding and wound complications,” Parvizi said. “It will allow all us to move away from expensive, inconvenient and dangerous drugs in the prevention of thromboembolism after joint replacement.”
Rothman Institute at Jefferson surgeons have begun to replace warfarin with aspirin for pre-surgical prophylactic clot prevention, he added.
Very interesting article. Wondering if there have been studies done comparing aspirin to enoxaparin for prevention of thromboembolism after joint replacement surgery and what the results are. Thank you for bringing this to our attention!